Carolyn E. Taylor - 16 Jul 2021 Form 4 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Role
Director
Signature
/s/ Jessica Morris as attorney-in-fact
Issuer symbol
TNXP
Transactions as of
16 Jul 2021
Transactions value $
$0
Form type
4
Filing time
27 Jul 2021, 21:46:47 UTC
Next filing
11 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNXP Stock Option Award $0 +237,437 $0.000000 237,437 16 Jul 2021 Common Stock 237,437 $0.9800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and is exercisable on the Issuer's 2022 Annual Meeting of Stockholders.